Ecopharmacovigilance is a crucial aspect of pharmacology that delves into the environmental impact of pharmaceutical substances, specifically focusing on their pharmacodynamics. Pharmacodynamics involves the study of how drugs interact with the body and the subsequent biological responses. In the context of ecopharmacovigilance, it extends beyond human health to assess the effects of pharmaceuticals on ecosystems and wildlife. Understanding the pharmacodynamics of drugs in the environment is vital for evaluating potential ecological risks. It encompasses the examination of how drugs persist, transform, and exert their effects in various environmental compartments. This field explores the intricate interplay between pharmaceuticals and non-target organisms, assessing both short-term and long-term impacts on biodiversity and ecosystem functioning. By scrutinizing pharmacodynamic aspects, ecopharmacovigilance aims to identify potential hazards posed by pharmaceutical residues in the environment and develop strategies to mitigate adverse effects. This involves comprehensive research to comprehend the fate of drugs in environmental matrices, their bioaccumulation, and potential consequences for ecosystems. Ultimately, integrating pharmacodynamics into ecopharmacovigilance practices ensures a holistic approach to pharmaceutical safety, addressing concerns beyond human health to safeguard the delicate balance of our ecosystems.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia